Terry Smith's position in Stryker is currently worth $2 Billion. That's 8.52% of their entire equity portfolio (3rd largest holding). The investor owns 1.41% of the outstanding Stryker stock. The first Stryker trade was made in Q1 2013. Since then Terry Smith bought shares 35 more times and sold shares on twelve occasions. The stake costed the investor $683 Million, netting the investor a gain of 192% so far.
Fundsmith''s 13F portfolio value rises to $25.55B, with top holdings in Microsoft, Meta Platforms, and Stryker Corp. Read a portfolio update here.
Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Ala...
Bioretec Ltd Inside information 20 May 2024 at 6:00 p.m. EEST TAMPERE, Finland, May 20, 2024 /PRNewswire/ -- Bioretec Ltd is pleased to announce that Mr. Ala...
Stryker (NYSE: SYK ) just reported results for the first quarter of 2024. Stryker reported earnings per share of $2.50. This was above the analyst estimate f...